While previous studies have not examined the association of RAD51B (rs8017304 and rs2588809), TRIB1 (rs6987702 and rs4351379), COL8A1 (rs13095226), COL10A1 (rs1064583), IL-9 (rs1859430, rs2069870, rs11741137, rs2069885, rs2069884), and IL-10 (rs1800871, rs1800872, rs1800896) genetic variants with the response to exudative AMD treatment, VEGFA SNVs have been the focus of several studies as potential biomarkers. The gene discussed is RAD51B; the disease is age-related macular degeneration.